Correction: Neoadjuvant Nivolumab plus Carboplatin and Paclitaxel in Patients with Locally Advanced Resectable Squamous Cell Carcinoma of the Head and Neck: A Phase II, Single-Arm Trial.

Authors

• Ralph G Zinner
• Eric V Mastrolonardo
• Jennifer M Johnson
• Kathryn Nunes
• Pablo Llerena
• Zachary Elliott
• Madalina Tuluc
• Joseph M Curry
• Christopher E Fundakowski
• Andrew Yampolsky
• Richard Goldman
• Charalambos C Solomides
• Stacey M Gargano
• Haresh Naringrekar
• Larry Harshyne
• Dawn Poller
• Benjamin E Leiby
• Voichita Bar-Ad
• Rita Axelrod
• Athanassios Argiris
• Adam J Luginbuhl
• David M Cognetti

Publication/Presentation Date

11-2-2026

Volume

32

Issue

21

First Page

5000

Last Page

5000

ISSN

1557-3265

Published In/Presented At

Zinner, R. G., Mastrolonardo, E. V., Johnson, J. M., Nunes, K., Llerena, P., Elliott, Z., Tuluc, M., Curry, J. M., Fundakowski, C. E., Yampolsky, A., Goldman, R., Solomides, C. C., Gargano, S. M., Naringrekar, H., Harshyne, L., Poller, D., Leiby, B. E., Bar-Ad, V., Axelrod, R., Argiris, A., … Cognetti, D. M. (2026). Correction: Neoadjuvant Nivolumab plus Carboplatin and Paclitaxel in Patients with Locally Advanced Resectable Squamous Cell Carcinoma of the Head and Neck: A Phase II, Single-Arm Trial. Clinical cancer research : an official journal of the American Association for Cancer Research, 32(21), 5000. https://doi.org/10.1158/1078-0432.CCR-26-3221

Disciplines

Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods

PubMedID

42968645

Department(s)

Administration and Leadership

Document Type

Article